期刊文献+

急性冠状动脉综合征患者出血事件发生的相关因素分析

Analysis of Related Factors of Hemorrhage Events in Patients with Acute Coronary Syndrome
原文传递
导出
摘要 【目的】探讨急性冠状动脉综合征(ACS)患者出血事件发生的相关因素。【方法】选取2005年5月至2015年5月本院确诊为ACS患者753例,按出血事件判别标准将其中发生出血事件的12例,纳入出血组。其余无出血的ACS患者采用分层随机抽样法选取48例纳入无出血组。比较两组患者临床特征、合并症、治疗方法及药物应用。【结果】本研究出血发生率为1.6%(12/753)。与无出血组相比,出血组患者年龄较大,住院天数较长(P〈0.05)。ACS患者合并心功能不全、合并肾功能不全、既往出血史的患者出血率较高(P〈0.05)。使用氯吡格雷、血小板膜蛋白Ⅱb/Ⅲa(GPⅡb/Ⅲa)受体拮抗剂、到上级医院行经皮冠状动脉介入术(PCI)、冠脉搭桥术(CABG)治疗的ACS患者出血率较高(P〈0.05)。【结论】年龄大、合并心功能不全、肾功能不全、既往出血史、行PCI和/或CABG、氯吡格雷、GPⅡb/Ⅲa受体拮抗剂治疗的ACS患者发生出血的可能性较大。 [Objective]To investigate the related factors of hemorrhage events in patients with acute coro- nary syndrome (ACS).[Methods] Seven hundred and fifty-three cases diagnosed as ACS in our hospital from May 2005 to May 2015 were selected, and 12 of them complicated with hemorrhage were regarded as hemor- rhage group according to the criterion of hemorrhagic events, while 48 of them without hemorrhage were se lected by stratified random sampling method as no hemorrhage group. The clinical features, complications, treatment and drug application of the two groups were compared.[Results]The complicated hemorrhage rate of this research was 1.6% (12/753). The patients' age in the hemorrhage group were older , and their hospital-stay time were longer than those in the no hemorrhage group ( P〈0.05). Additionally, patients complicated with cardiac insufficiency, renal insufficiency and past history of hemorrhage got higher rate of hemorrhage ( P〈0.05). ACS patients treated with clopidogrel and platelet membrane protein Ⅱb/Ⅲa(GP Ⅱb/Ⅲa)receptor an tagonist or underwent PCI and (or) CABG in superior hospitals got a higher rate of hemorrhage ( P〈0.05). [Conclusion] ACS patients with senior age, combined cardiac insufficiency, renal insufficiency, previous histo ry of bleeding, once underwent PCI and / or CABG, or treated with c[opidogrel or GP Ⅱb/Ⅲa receptor an- tagonists are more vulnerable to hemorrhage.
作者 陈婧
出处 《医学临床研究》 CAS 2016年第7期1285-1287,共3页 Journal of Clinical Research
关键词 急性冠状动脉综合征 出血 危险因素 Acute Coronary Syndrome Hemorrhage Risk Factors
  • 相关文献

参考文献13

二级参考文献72

  • 1沈杰,张奇,张瑞岩,张建盛,胡健,杨震坤,张宪,郑爱芳,沈卫峰.替罗非班在急性冠脉综合征患者中应用的安全性和出血相关因素分析[J].临床内科杂志,2007,24(1):14-17. 被引量:17
  • 2宋现涛,吕树铮,陈韵岱,苑飞,林运,田锐,陈欣,金泽宁,周渊,葛长江,孟康,柳弘.经皮冠状动脉介入治疗后患者住院期间合并上消化道出血分析[J].中华心血管病杂志,2007,35(4):308-311. 被引量:36
  • 3YUSUF S,MEHTA S R,CHROLAVICIUS S,et al.Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction:the OASIS-6 randomized trial[J].JAMA,2006,295:1519-1530.
  • 4VARIN R,MIRSHAHI S,MIRSHAHI P,et al.Clot structure modification by fondaparinux and consequence on fibrinolysis:a new mechanism of antithrombotic activity[J].Thromb Haemost,2007,97:27-31.
  • 5WALENGA J M,JESKE W P,BARA L,et al.Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide[J].Thromb Res,1997,86:1-36.
  • 6MEHTA S R,YUSUF S,GRANGER C B,et al.Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux,a synthetic factor Xa inhibitor,in patients with non-ST-segment elevation acute coronary syndromes[J].Am Heart J,2005,150:1107-1109.
  • 7Potsis TZ,Katsouras C,Goudevenos JA,et al.Avoiding andmanaging bleeding complications in patients with non-ST-segmentelevation acute coronary syndromes.Angiology,2009,60:148-158.
  • 8Moscucci M,Fox KA,Cannon CP,et al.Predictors of major bleed-ing in acute coronary syndromes:the global registry of acute coro-nary events(GRACE).Eur Heart J,2003,24:1815-1823.
  • 9Berkowitz SD,Granger CB,Pieper KS,et al.Incidence and pre-dictors of bleeding after contemporary thrombolytic therapy formyocardial infarction.The global utilization of streptokinase andtissue plasminogen activator for occluded coronary arteries(GUS-TO)I investigators.Circulation,1997,95:2508-2516.
  • 10Marianne M,Kathleen A Stringer A,et al.Discrepancies in Iden-tification of bleeding events after percutaneous coronary Interven-tion.Pharmacotherapy 2007,27:36-40.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部